Shares in Novo Nordisk fell as much as 3.5 per cent on Monday after detailed trial data on its experimental obesity drug ...

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term ...

GPs in England are now allowed to prescribe Mounjaro to severely obese people who also suffer from a range of other health ...

The combination offers a potential solution to one of the key problems that’s emerged with popular obesity shots.

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments ...

Find insight on Novo Nordisk, Bumrungrad Hospital, Riverstone Holdings, and more in the latest Market Talks covering Health ...

The report spotlights China’s rapid biopharma advancement, alongside a GLP-1 surge, caution surrounding M&A, and a rise in ...

The mass rollout of weight loss jabs such as Mounjaro on the NHS in England will begin today as GPs are allowed to prescribe the drugs for the ...

U.S. stocks are drifting, and oil prices are flip-flopping following the United States’ bunker-busting entry into Israel’s ...

Futures on Wall Street trimmed early losses on Sunday evening local time, even as the US attacked three Iranian nuclear ...